AMSTERDAM (September 1, 2021)—Royal Philips today announced an update in connection with the June 14, 2021 recall notification for specific Philips sleep and respiratory care devices that was issued to address potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam component in these devices. More than half of the affected devices in use globally are in the United States. The vast majority (>80%) of the registered affected devices in the U.S.
sleep apnea
SAN DIEGO (August 16, 2021)—ResMed, a provider of digital health and sleep apnea treatment, launched AirSense 11, available first in the United States, the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea start and stay on therapy to treat and manage obstructive sleep apnea.
HME providers, industry working out impacts of Philips device recall
AMSTERDAM (June 14, 2021)—On Monday, Philips announced it is voluntarily recalling nearly 4 million CPAP machines and noninvasive ventilators to ensure patient safety in consultation with regulatory agencies. Corrective actions include the deployment of updated instructions for use and a repair and replacement program for affected devices.
PITTSBURGH, Penn. (June 8, 202)—sovaSage Incorporated, a Pittsburgh based company, announced the latest release of its TherapistAssist software (version 7.0). This new release provides an effortless and instantaneous handoff of mask and mask sizing recommendations between sleep labs, home sleep study services and durable medical equipment (DME) providers.
CAESAREA, Israel (April 12, 2021)—Itamar Medical Ltd., a medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced results from a recent survey to health care professionals that covered sleep testing dynamics in their practices during 2020 and expectations for future use of home sleep apnea testing (HSAT) versus polysomnography (PSG) testing performed in sleep laboratories.
SAN DIEGO (March 16, 2021)—ResMed, a digital health company, announced the results of a nationwide survey of 1,000 adults, which revealed that for half of Americans, stress over the past year is negatively impacting the quality of their sleep—and many are ignoring sleep challenges that could point to a larger underlying health concern.
AMSTERDAM (March 10, 2021)—Royal Philips, a global provider of health technology, announced the findings of its sixth annual sleep survey in a report titled “Seeking Solutions: How COVID-19 Changed Sleep Around the World.”
IRVINE, Calif. (February 8, 2021)—GoPAPfree, a homecare provider of oral appliance therapy for obstructive sleep apnea, announced the launch of their new product O2Vent Optima, a highly effective and more convenient alternative to CPAP therapy. This patented and exclusive appliance is the only device with integrated airway technology and increases the response rate to sleep apnea therapy by 40% compared to standard mouthguards.
WINTER HAVEN, Fla. (February 1, 2021)—3B Medical, Inc. is proud to announce receiving FDA 510(k) clearance on its new third generation bi-level device, the Luna G3 Auto-BPAP.
PHOENIX, Ariz. (January 28, 2021)—Optipillows EPAP Mask announced a new collaborative partnership with McArthur Medical Sales Inc. for immediate distribution of Optipillows EPAP Mask within Canada.
CAESAREA, Israel (December 11, 2020)—Itamar Medical Ltd., a medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, commented on the recent release of the 2021 Physician Fee Schedule from the U.S. Centers for Medicare & Medicaid Services (CMS). This Fee Schedule represents the third year of a four-year proposed plan to reevaluate reimbursement in home sleep apnea diagnostic codes.
CAESAREA, Israel (November 17, 2020)—Itamar Medical Ltd., a medical device and digital health company leading the integration of sleep apnea management into the cardiac patient care pathway, today announced the preliminary results from two large claims database studies that demonstrated the significant health economic benefits of effective sleep apnea management for patients with chronic cardiovascular diseases.
ST. LOUIS (November 11, 2020)—Responsive Respiratory introduces upgraded sanitizing and travel case for the Purify O3 CPAP Sanitizer.
The Purify O3 sanitizer utilizes ozone technology to disinfect reusable medical supplies such as CPAP/BiPAP accessories, nebulizers and more. The newly upgraded sanitizing and travel case offers 53% greater capacity. The Purify O3 is independently laboratory tested to kill 99.99% of bacteria and germs in a short 35-minute cycle.
4 steps to increasing compliance & keeping users healthy
PITTSBURGH, Penn. (September 29, 2020)—sovaSage Incorporated, a Pittsburgh based company, announced the release of its new TherapistAssist software. This revolutionary product will change the way homecare providers manage their sleep apnea patients.
It’s estimated that 54 million to 60 million people have sleep apnea in the United States, and 80% of these people are going undiagnosed and untreated. Economically, sleep apnea also costs the U.S approximately $149.6 billion annually.
SAN DIEGO, (September 1, 2020)—ResMed announced the launch of its AirTouch N20 nasal mask, the company’s first CPAP nasal mask with a memory foam cushion and softest nasal mask ever.